Clinical Trial Update: HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HDR brachytherapy using 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET, and multiparametric MRI in prostate cancer; trial status terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68-Ga-PSMA-11
• 68-Ga-RM2 (68-Ga-RM2)

Snippet

Sponsor: Andrei Iagaru | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-02-01